In gastric adenocarcinoma, the prognostic impact of RelA expression appears to be somewhat conflictive, as overexpression was reported both to be an indicator of adverse (Sasaki et al, 2001; Yamanaka et al, 2004) and favourable (Lee et al, 2005) patient prognosis. This evidence concerns the gene RELA and gastric adenocarcinoma.